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I
Ferguson, Robert B., M.S., August 1978 Microbiology
Immune Response in Rabbits to Spoyotb^rix schenckii (56 pp.)
Director: John J, Taylor
The nature of the immune response to Sporothrix schenckii 
and its role in resistance to pulmonary sporotrichosis are equivocal. 
Although case reports indicate a relatively low incidence of pulmonary 
disease when contrasted with the typical lymphocutaneous infection, 
skin test surveys suggest that inapparent pulmonary infections may be 
quite common in areas endemic for the more characteristic lymphatic 
syndrome. Evidence for a more effective immune response to 
schenckii in pulmonary than in lymphocutaneous tissues is lacking.
The present study was undertaken to determine whether immuno­
globulins contribute to resistance through opsonizing and/or fungi­
static (fungicidal ?) activity, and to correlate the phagocytic and 
antifungal activities of alveolar macrophages with pulmonary resis­
tance.
Rabbits sensitized with schenckii introduced by several 
routes were examined for their immune response. Humoral activity was 
assayed by agglutination, precipitation, and fungal inhibition.
Cellular responses were examined using skin tests, macrophage migration 
inhibition analysis, phagocytic efficiency and fungistasis assays. 
Comparisons were made between sensitized and unsensitized animals.
Sera from both sensitized and unsensitized animals were fungi­
cidal when mixed with schenckii conidia, but there was no well- 
defined difference evident in the majority of the dilutions tested. 
However, when compared with sera from unsensitized (normal) rabbits, 
sera from sensitized (immune) animals significantly enhanced both 
phagocytic and fungicidal activities of alveolar macrophages. Macro­
phages recovered from animals sensitized by inhalation possessed 
greater phagocytic and fungicidal activities than those from animals 
sensitized by other routes, and sensitization with viable cells 
produced greater macrophage activity than sensitization with killed 
cells.
The results suggest that inhalation of viable schenckii 
conidia leads to a dramatic sensitization of pulmonary macrophages, 
and a decreased potential for expression of a pulmonary syndrome. 
Immunoglobulins appear to contribute to phagocytic and perhaps anti­
fungal resistance. Artificial immunization with living schenckii 
conidia confers a more efficient resistance in rabbits than immuniza­
tion with killed cells.
II
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Chapter 1 
INTRODUCTION
General Introductory Statements 
Sporotrichosis is generally manifested as a chronic lymphocu— 
taneous disease of man and other animals. It is acquired by cutane­
ous inoculation, or occassionally by inhalation of conidia produced 
by the polymorphic fungus, Sporothrix schenckii. Characteristics of 
the common form are frequently ulcerating and draining nodules of sub­
cutaneous and cutaneous tissues and adjacent lymphatics. Spread to 
other tissues, such as the central nervous system, muscle, bone, and 
genitourinary tract may occur,
Schenck (46) at Baltimore's John Hopkins University in 1898, re­
corded the first clinical picture of sporotrichosis. Two years later, 
Hektoen and Perkins (20) reported the second case in the United States, 
described a sporotrichic skin lesion on the finger of a small boy, and 
named the fungus, Sporothrix schenckii. In the early 20th century, 
deBeurmann, Raymond, Matruchot, and Gougetot (46) reported numerous 
cases in France, and Schenck's organism was remaned, Sporotrichum 
schenckii. From the early 1900s until the 1920s, the incidence of 
sporotrichosis in Europe was high, but has decreased measurably since 
then.
In 1907, in Brazil, Lutz and Splendore (46) identified natural
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sporotrichosis in rats and later Carougeau (46) described the in­
fection in horses. Sporotrichosis has also been recorded in dogs, 
cats, insects, boars, mice, hamsters, mules, foxes, camels, and parrots 
(16,38, 46, 50, 58).
In 1962, Carmichael (46) suggested that there were indeed differ­
ences between Sporotrichum and Sporothrix based on sporulation. De­
spite these differences, there is a tendency among medical personnel to 
use the two names synonymously. Recent revisions in the taxonomy and 
systematics have resulted in the two genera being mutually exclusive. 
The generic name of Sporothrix has been adopted for the etiologic agent 
of sporotrichosis. Sporotrichum aureum, the lectotype of the genus 
Sporotrichum, is characterized on the basis of a new isolate as an im­
perfect basidiomycete (1, 9, 57). Sporothrix, unlike Sporotrichum, is 
classified solely as a hyphomycete; no clamp connections have been ob­
served, thus negating any affinity with the basidiomycetes. Barron (3) 
related that in Sporothrix the conidia are sympodulospores and in 
Sporotrichum they are aleuriospores.
Taylor (53) suggested that schenckii is a heterogeneous form- 
species complex consisting of aniscigerous states of several 
Ophiostoma (=Ceratocystis) species. His conjecture has been supported 
by recent antigenic (43), rhamnomannan (55), and whole cell analyses 
(55) of schenckii isolates.
Ajello and Kaplan (1) described a new variant of Ŝ . schenckii,
Ŝ . schenckii var. luriei which differs in the tissue phase from the 
typical yeast-like phase, in that the former had larger cells, produced 
sclerotica, and frequently multiplied by fission rather than by budding
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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In 1968, Mariat (36) hypothesized that physiological properties 
of Ophiostoma and Ŝ . schenckii are remarkably similar. Taylor (53) re­
cognized similarities between 2= schenckii and several species of 
Ophiostoma based on culture, morphologic, serologic characteristics, 
and mouse virulence, Andrieu (2) has recently determined that there 
was sufficient antigenic relationship among several strains of 
schenckii tested to assume that they were a homogeneous group, and 
that Ophiostoma sp. represented the perfect state of schenckii. 
Similar observations have been made by DeHoog (12).
The relatively slender hyphal dimensions of schenckii are of 
diagnostic significance (although not pathognomonic) since hyphae of 
most other pathogenic fungi are considerably broader. Spherical or 
pyriform amerospores (2.0-5.0 in length) develop laterally or sym-
podially from the conidiophores. Initially one may assume that the 
conidia are separated from the bearing structure by a short, but con­
stant distance; but after careful oil immersion observation, fine hair­
like stalks (sterigmata) of attachment are seen. By modern definition, 
Sporotrichum does not possess sterigmata; conidia are borne as aleurio-* 
spores directly from the lateral hyphae, and thereby serve as another 
basis for differentiation.
Some of the conidia may produce one or more buds at their tips 
after separating from their conidiophores. Taylor (54) described the 
presence of secondary conidia and their mechanism of production. Pri­
mary sympodulospores may germinate to produce one or more sympodulae, 
which in turn bear secondary sympodulospores. It is likely that the
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latter represent the yeast-like tissue phase of typical forms of 
Ŝ o schenckii o
At 37*C, or in host tissues, the mycelial phase converts to a 
so-called yeast-like phase. Strains isolated from nature vary in their 
ability to grow at 37*C. Tissue phase variation at the species level 
substantiates claims that schenckii should be referred to as poly­
morphic rather than a dimorphic organism (1). Phase transition is 
dependent on thermal state, but generally appears to be independent 
of the nutritional status of the supporting medium (30).
£.• schehckii is distributed as a soil saprobe in temperate and 
tropical climates. Through skin testing, sporotrichosis is found to 
be highly endemic in humid areas such as Brazil, Uruguay, and South 
Africa, In Mexico, where the climate is, in contrast, considerably 
more arid, sporotrichosis poses as the most common subcutaneous my­
cosis. In temperate countries such as the United States, Canada, and 
France, infection is commonly encountered through gardening accidents.
The distribution of cases within a given population appears to 
be associated with occupation, rather than with genetic, age, or racial 
influences. Those individuals who are in the most frequent contact 
with the soil generally present the majority of infections.
According to Rippon (46), deBeurmann and Gougerot considered 
sporotrichosis to be an opportunistic disease, infecting only the pre­
disposed. Other investigators assert that predisposition is not a re­
quirement, citing many subclinical cases from which the organism has 
been cultured. Perhaps one may postulate that underlying disease, mal­
nutrition, or a faulty immunological system may be necessary for the
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dissemination of the disease, but not required for the common cu­
taneous and subcutaneous form of infection»
Early reports stated that numerous cigar-shaped bodies of the 
yeast-like phase were observed from sporotrichic lesions. But today, 
pathologists rarely find tissue-phase organisms by direct examination 
of lesion aspirates. Lurie (33) observed in tissue sections stained 
with hematoxylin and eosin (HSE) what appeared to be a capsular halo 
around the organisms, but later attributed this phenomenon to shrinkage 
of the fungus during the fixation process.
The asteroid body, which is a common histopathological observa­
tion in South American and South African cases, is rarely seen in the 
United States. It consists of a compact central mass, about which 
radiates a homogeneous eosinophilic material. The diameter of the 
central mass ranges from 5.0-10.0 ̂ m  and stains poorly with H&E.
Serial sections are necessary to detect asteroid bodies, and they are 
more frequently observed from secondary than from primary lesions (46), 
There have been various theories as to the nature of their formation. 
Lurie (33) postulated that the homogeneous eosinophilic projections com­
posing the stellate arms of the asteroid represent a host humoral re­
sponse to antigenic stimulation. Although this host response theory 
seems to be the most recent and accepted view, other investigators have 
based its appearance on associated growth of particular bacteria, or the 
result of an actual product of the invading fungus. Lurie (34) 
stated that the asteroid body is formed by the precipitate of a soluble 
antigen-antibody complex which is deposited on the surface of the 
tissue-phase propagule.
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Immunological Aspects 
Natural resistance to sporotrichosis in unsensitized individuals 
is quite high. Although subclinical infections may occur in many 
healthy individuals, for some reason(s), they are frequently able to 
abort clinical disease* Using two groups of children (clinically a- 
symptomatic for sporotrichosis), Pereira (45) skin tested them with 
sporotrichin* One group of children, from a low socioeconomic class, 
presented a 10.8% positive skin reactivity, whereas the other group 
of children, which was isolated in a sporotrichosis-free area, yielded 
a 6% reactivity. The resulting immunity to infection and/or disease 
is perhaps due largely to a humoral and/or a cell-mediated response 
mounted by the host. The characterization of the response leading to 
resistance to sporotrichosis is basically unknown, hence the relevance 
of the research conducted in this paper.
Once the etiologic agent successfully penetrates the host's pri­
mary line of defense, body constituents (humoral and/or cellular) must 
act if the host is to resist clinical disease. There is much specula­
tion as to the immunological mechanism(s) involved in the suppression 
of clinical sporotrichosis.
The vast majority of research involving antifungal effects of cell- 
free serum has dealt with dermatophytic infections. Blank and co­
workers (5) determined that cell-free serum was fungistatic to pellet 
inocula of Trichophyton mentagrophytes and rubrum. After prolonged 
incubation, the fungi began to grow out. Heating the serum to 56^C for 
30 minutes reduced the inhibitory activity, but did not destroy it com­
pletely. Lorincz, Priestley, and Jacobs (32) reported dializable.
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heat labile, antidermatophytic substances in human and mouse serum and 
tissue fluids,
Baum and Artis (4) were able to detect inhibitory influence of 
human cell-free serum on the growth of Cryptococcus neoformans, 
Histoplasma capsulatum, and schenckii. They postulated that the 
fungistasis was unrelated to past clinical infections and appeared to 
be a nonspecific resistance inherent in the serum. Of these three 
fungi tested, inhibition of Ŝ . schenckii was least dramatic, but still 
observable.
Roth and co-workers (47) suggested that the inhibition of a 
yeast (Candida albicans) by cell-free serum may be based on a different 
mechanism than that active against a dermatophyte. The antidermato­
phyte capacity of serum is present from birth and is in a similar con­
centration to that found in maternal blood. This antidermatophytic 
titer can be reduced by dialysis and heating the serum to 56*C for 
30 minutes. The serum of "normal" human adults has inhibitory ac­
tivity against Ĉ . albicans, but unlike the activity against dermato­
phytes, its level is much reduced until the third month of life.
Heating the serum does not reduce the anti-Candida activity.
It appears that with certain fungi, complement may be required 
for fungistasis, either by itself, or in a helper role. Depending 
on the fungus, an acquired specific antibody response may be protec­
tive (as in Ĉ. albicans) , whereas the serum factors directed against 
the dermatophytes may be totally nonspecific. Dr. Gerald Baum (per­
sonal communication) hopes that newer techniques of protein separa­
tion may help elucidate the fungistatic serum protein fractions.
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Complement-fixing (CF) antibodies present in sporotrichosis, 
as in coccidiomycosis and histoplasmosis, do not seem to be protec­
tive (6, 17, 44, 48, 59). In fact, elevated CF antibody titers appear 
to parallel the activity of infection or degree of tissue involvement, 
rather than the degree of host resistance mounted. Jones and co­
workers (25) followed the CF antibody titer during therapy of two 
patients with extracutaneous sporotrichosis. A drop in titer was 
manifested by clinical improvement, Norden (44) broadly stated that 
a rising CF titer in systemic mycoses is usually an unfavorable sign, 
indicating dissemination of the fungus.
Karlin and Nielsen (26) related that patients with articular or 
pulmonary sporotrichosis have higher agglutination titers than patients 
with the cutaneous form of the disease. Blumer (8) concluded from her 
comparative evaluation of 5 serological techniques that the slide latex 
agglutination had greater specificity and sensitivity than immuno­
diffusion, complement fixation, or indirect fluorescent antibody anti­
body in the diagnosis of sporotrichosis. Jones (25) concluded that 
either yeast or broth-coated latex antigens serve as a better reagent 
for detecting antibodies to Ŝ . schenckii than gel precipitation or com­
plement fixation.
Karlin and Nielsen (26) postulated that individuals with humoral 
antibodies to Ŝ . schenckii probably also exhibit delayed hypersensi­
tivity to the fungus. Skin testing is an extremely useful diagnostic 
tool in detecting individuals who are subclinically infected with Ŝ. 
schenckii (45)„ Norden (44) was unable to demonstrate a delayed dermal 
hypersensitivity or agglutination reaction in rabbits which received
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a subcutaneous injection of viable mycelial-phase schenckii.
Rabbits in which Norden (44) administered a single intraveneous in­
jection of viable yeast-phase schenckii, demonstrated positive 
agglutination and precipitin reactions 10-15 days following infection, 
but the rabbits showed no visible signs of disease. Rabbits which re­
ceived repeated daily intraveneous and intraperitoneal injections in 
increasing doses, showed a slight appetite and weight loss. Norden (44) 
stated that pigmentation or phase variation had no effect on the agglu­
tination response. Agglutination reactions were fairly equal regardless 
whether antigenic stimulation was provided by pigmented strains (yeast- 
and mycelial-phase) or nonpigmented strains (yeast- and mycelial-phase). 
There was no difference in stimulatory response of agglutinins or pre- 
cipitins when he altered his antigen by subjecting it to heat or forma­
lin treatment.
In vitro complement fixation and agglutination titers appear to 
discount any protective value of these antibodies against sporotrichosis. 
However, Lurie's (33) studies indicate that in sporotrichosis, the 
presence of asteroid bodies probably reflects an vivo humoral re­
sponse that effectively localizes the antigen and prevents dissemination. 
If opsonins also constitute, in part, the vivo humoral response of the 
asteroid body (14, 37, 41), then it would appear that antibodies may be 
active in resistance to schenckii by aiding phagocytosis.
Howard (21) working with mouse peritoneal macrophages, determined 
that the generation time of H. capsulatum in specifically sensitized 
macrophages was significantly increased over the generation time within 
nonsensitized macrophages. Sensitized macrophages that were washed 
prior to sensitization, had a decreased inhibitory effect, but fungi-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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static activity was restored when sensitized lymphocytes were added.
This would imply the importance of lymphocytes as mediators of fungi­
stasis. Although lymphocytes are most likely the mediators of this 
reaction, they have no direct effect themselves (29).
Howard (22, 23) emphasized the observation that yeast-phase IÏ, 
capsulatum still retained viability following a 24-hour residence with­
in sensitized macrophages.
Epidemiologic studies indicate a relatively low incidence of pul­
monary sporotrichosis (primary and secondary) compared to the typical 
lymphocutaneous form. Despite this, Baum (5) urged caution in dis­
missing the possibility of clinical pulmonary sporotrichosis. Feeling 
that the disease has frequently been overlooked in the past, he at­
tributed the lack of reports to the following: pulmonary sporotricho­
sis markedly resembles other granulomatous diseases based on x-rays 
and clinical patterns, lack of familiarity with mycotic techniques, 
difficulty in finding the organism histologically, and the mere lack 
of appreciation that schenckii can cause pulmonary disease. Skin 
test surveys suggest that inapparent pulmonary sporotrichosis may be 
common in endemic areas, but supporting data and evidence for enhanced 
pulmonary response to conidia contact are lacking.
The nature of the immune response and its relationship to pulmon­
ary sporotrichosis is equivocal. The conducted research was intended 
to determine whether immunoglobulins can contribute to host resistance 
through opsonizing or fungistatic (fungicidal ?) activity. Additionally, 
attempts were made to correlate resistance with phagocytic and fungi­
static (fungicidal ?) action of alveolar macrophages.
Immune responses of rabbits to Ŝ . schenckii will be determined fol-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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lowing (1) intramuscular injection of viable conidia and hyphal frag­
ments, (2) immunization with merthiolate-killed conidia and hyphal 
fragments injected intraveneously, and (3) pulmonary sensitization 
with aerosolized viable conidia.
Agglutination and/or precipitation titers will be determined on 
sera collected at various time intervals from rabbits sensitized by 
each of the above mentioned routes.
Onset of delayed skin reactivity will be determined in each of the 
experimental models.
Cell-free serum studies will be conducted to determine whether sera 
possess fungistatic activities.
Alveolar macrophages will be procured from both sensitized and 
unsensitized rabbits. Using these cells, in vitro correlates of de­
layed hypersensitivity will be conducted by migration inhibition factor 
(MIF) assays and phagocytic and fungistatic (fungicidal ?) indices will 
be determined. All cellular studies will be performed with "immune" 
and "normal" serum to determine if there are humoral components which 
affect phagocytosis and fungistasis.
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Chapter 2 
MATERIALS AND METHODS 
Fungal Cultures
Cultures of schenckii 425 isolated from a case of sporotricho­
sis were initially obtained from the Center for Disease Control, 
Atlanta, Georgia. From stock cultures, subcultures were inoculated 
onto slants of potato dextrose agar (PDA) (Difco Laboratories, Detroit, 
Michigan), Sabouraud dextrose agar (Difco Laboratories), and Mycose1 
agar (Baltimore Biological Laboratory, Cockeysville, Maryland), and 
incubated in screw-cap tubes at 25**C in a humidity-controlled incuba­
tor.
Broth flasks were prepared by inoculating 500 ml Erlenmeyer flasks 
containing 100 ml Sabouraud dextrose broth (Difco Laboratories) plus
0.1% yeast extract (Difco Laboratories) with schenckii 425. These 
flasks were incubated at room temperature on an Eberbach horizontal 
shaker for a period from 10 days to 2 weeks.
Tissue Culture Media and Buffer Solutions
Minimal essential medium (MEM) with Earle's balanced salt solu­
tion (Grand Island Biological Company, Grand Island, New York) was used 
as the tissue culture medium. Crystalline MEM was reconstituted with 
triple distilled water. The medium was buffered by addition of 2.2 g/1 
NaHCOg. Penicillin and streptomycin were incorporated to a final con-
12
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centration of 100 units and 100 pg respectively, to retard bacterial 
growth. The solution was adjusted to pH 6.8 with IN HCl or IN NaOH. 
Following filter sterilization, the pH of the MEM was 7.0 +/- 0.1.
The medium was then tightly sealed and stored at 4*C.
Phosphate-buffered saline (PBS) was utilized as a physiological 
buffering medium. Stock buffer solutions of Na^HPO^ and KHgPO^
(0.15M) were prepared in deionized distilled water and added to an 
equal volume of 0.85% NaCl. The PBS (pH 7.2) was autoclaved and stored 
in tightly capped prescription bottles at room temperature.
Antigen Preparation (unless stated otherwis^, all 
cellular antigens had a concentration of 10 colony 
forming units/ml (cfu))
1. Merthiolate-killed Ŝ . schenckii 425: Merthiolate (final con­
centration of 1:10,000) was added to aliquots of hyphae and conidia.
oAfter several hours incubation at 37 C, platings were made on nutrient 
agar (Difco Laboratories) and Mycosel agar to check for contamination 
and loss of viability. The antigen suspensions were stores in PBS at 
4*C.
2. Viable schenckii 425: Viable cultures were grown in Sabou­
raud dextrose broth containing 0.1% yeast extract in flasks incubated 
at room temperature on an Eberbach horizontal shaker. Conidia were 
isolated from the hyphal mat by passing the culture material through 
an absorbent pad (47 mm diameter; 0.85 mm thick) (Millipore Filter
Corporation, Bedford, Massachusetts). The conidial suspension was
owashed twice in PBS, placed in 3.0 ml aliquots, and stored at 4 C.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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3. schenckii 425 protoplasm: Crude protoplasm was obtained
by grinding the fungus in a mortar and pestle with type 305 alumina 
(Sigma Chemical Company, St. Louis, Missouri), Following 1 hour of 
pulverization at 4®C, the mixture was centrifuged and the supernatant 
fluid was concentrated by pervaporation at 4^C. The protein concen­
tration of the protoplasm suspension was estimated by ultraviolet 
absorbtion at 260 nm and 280 nm (31), and sterilized by passing it 
through a 0.22 jm filter (Millipore Filter Corporation). Aliquots 
consisting of 0.5 ml were prepared and stored in the frozen state.
Immunization of Test Animals
1. Inoculation of viable schenckii 425 by intramuscular in­
jection: Rabbits were initially sensitized with 3.0 ml viable 
schenckii 425 inoculated intraperitoneally (ip) and 1.0 ml intramus­
cularly (im). Monthly im booster injections of viable fungus were 
given and the animals were sacrificed approximately 10 days following 
the last booster and after becoming skin test positive,
2. Inoculation of merthiolate-killed schenckii 425 by intra­
veneous injection: Rabbits were initially sensitized with 1.0 ml
merthiolate-killed schenckii 425 given intraveneously (iv).
Booster iv injections of the same dosage were given every 3-4 days 
until the animals were skin test positive. The rabbits were sacri­
ficed 3 days following the last booster injection.
3. Inoculation by aerosolization of viable schenckii 425: 
Test and control rabbits were blindfolded and placed in the Middle-
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brook chamber, A suspension of viable Ŝ . schenckii conidia (6.0 ml 
suspension) was nebulized into the compartment. Immediately following 
aerosolization, duplicate control rabbits were removed from the chamber 
and sacrificed with a nembutal overdose. The lungs from these animals 
were removed, weighed, homogenized in a Waring blender, and plated 
onto Mycosel agar to determine the number of conidia that reached the 
lungs.
To establish what effect the homogenization procedure would have 
on the viability of conidia, lungs of a rabbit were removed, weighed, 
and placed in a Waring blender jar containing a known number of viable 
conidia. Plate counts were performed following homogenization.
Ten days after becoming skin test positive, duplicate test animals 
were sacrificed. Lungs were lavaged and alveolar macrophages were ob­
tained for cellular studies described below.
Another set of duplicate test animals received a second inoculum 
of conidia delivered by aerosol 10 days after becoming skin test posi­
tive. Two control rabbits simultaneously exposed were sacrificed im­
mediately and plate counts were made of lung homogenates. Five days 
later, these 2 test rabbits were sacrificed and alveolar macrophages 
obtained for upcoming cellular studies
In Vivo Testing
1. Skin testing: Test animals (before and after sensitization)
and control animals were skin tested by intradermal injection of 0.1 
ml crude protoplasm (0.27 mg protein/0.1 ml) and washed merthiolate- 
killed Ŝ . schenckii 425. Intradermal injections consisting of 0.1 ml
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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PBS and O d  ml distilled water were used as skin test controls.
Arthus and delayed skin reactions were recorded qualitatively (with­
out the use of calipers).
In Vitro Testing
1. Agglutination testing: Test animals were bled prior to,
and at various intervals following sensitization. Aliquots of whole
sera and serum dilutions (to 1:2048) were combined with an equal
volume of merthiolate-killed 5̂ . Schenckii 425. The tubes were mixed,
osealed, and placed in a 37 C incubator for 2 hours, followed by over­
night storage at 4^C. The agglutination titers were observed micro­
scopically and were compared to agglutination titers of similar dilu­
tions of sera from unsensitized rabbits. The comparison was utilized 
as the baseline value.
Agglutination titers of sera from 8 unsensitized rabbits were 
determined using saline controls (PBS plus conidia); these titers 
were also used as a baseline.
"Immune" sera were so designated by their ability to agglutinate 
merthiolate-killed antigen at titers in excess of "normal"sera. In­
creased fungistasis of cell-free serum (see below) was also used as a 
criterion to define "immune"serum.
2. Precipitin testing: Sera from test animals (excluding those
exposed to aerosols) were used to determine precipitin titers. Serum 
(showing no precipitin bands) from unsensitized rabbits was used as a 
baseline control. Serial dilutions (to 1:512) of the test and control
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sera were prepared. Tubes 6 mm in diameter were partially filled with 
undiluted crude protoplasm (0.27 mg protein/0.1 ml) and overlaid with 
whole serum or the diluted serum, forming a definite interface between 
the antigen and antiserum. These tubes were sealed and left at room 
temperature in the vertical position. Periodic observations for the 
appearance of precipitin bands over a 24-hour period were made.
3. Cell-free serum assays: Five dilutions were made from serum 
of unsensitized and sensitized rabbits and combined with suspensions of 
known viable schenckii 425 populations. Using MEM as a tissue cul­
ture support medium, the suspensions (serum plus conidia) were main­
tained over a period of 12 hours. Duplicate platings on Mycosel agar 
were made at 5 different time intervals. Differences in colony counts 
between test and control rabbits were plotted.
4. Cellular studies :
a. Harvesting alveolar macrophages: The technique of
Myrvik, Leake, and Fariss (39) was used with the following 
exceptions: the lungs were not removed from the rabbits,
but a 45-ml volume of cold, heparinized MEM waS injected 
into the trachea of the sacrificed rabbit ; the thorax was 
gently massaged, the trachea severed, and the macrophages 
collected by gravity into cold siliconized glassware. The 
macrophage yield was determined by direct cell count.
b. Migration inhibition factor (MIF): The technique of George
and Vaughan (18) was used with the following exceptions:
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the capillary tubes, 2/3 filled with cellular suspension, 
were sealed by heat; the coverslip was held in place, not 
with paraffin, but with a rubber gasket and a securable 
screw type washer. Following incubation, the migration 
pattern of the macrophages was enlarged with the aid of 
a Simon Omega model D-2 enlarging rapture. The patterns 
were then traced on bond paper and weighed on a Mettler 
H2QT balance. The index of migration was calculated by 
comparison with control migration patterns (28).
All MIF tests were carried out incorporating 10% serum 
from either unsensitized or sensitized rabbits. The state 
of sensitization was previously determined by agglutina­
tion testing. Delayed hypersensitivity of the cellular 
constituents was ascertained, to this point, by skin 
testing.
c. Phagocytic and fungistatic assays: With the remaining
macrophages (those not used in the MIF), phagocytic and 
fungistatic tests were performed. Alveolar macrophages 
at the concentration of 10^/ml (10^/total volume) were 
combined with 10^ conidia/ml in MEM with 10% "immune" 
serum or 10% "normal"serum. At 8 different time intervals 
over a 48-hour period, smears were made of the macrophage/ 
conidia suspension, and stained with periodic acid schiff 
(PAS) as described by Humison (24) . Upon examination of 
these slides, 50 macrophages were counted. The actual
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number of intracellular conidia based on these 50 macro­
phages was plotted versus time. The maximum number of 
intracellular conidia/macrophage was also recorded at. 
each time interval.
Following preparation of the smear for the phagocytic 
index, aliquots of the macrophage/conidia suspension 
were taken at each time interval (8 intervals over the 
same 48-hour period) and passed through a distilled 
water dilution followed by a series of additional 10- 
fold dilutions in PBS, The first dilution (10 in 
distilled water was performed in order to create a hypo­
tonic environment to lyse the macrophages and expose the 
phagocytized, but still viable, conidia for plate counts. 
The subsequent 10-fold dilutions in PBS were performed 
to re-create physiological conditions, so as not to lyse 
conidia, and also to establish a dilution of viable co­
nidia which could be counted (approximately 100 colonies/ 
plate). A conidia control (conidia in MEM without macro­
phages) was performed to establish a baseline viablilty 
curve and a basis to compare the effect of macrophages 
on conidia. The platings were made in order to determine 
what, if any, loss of conidial viability had occured in 
the presence of macrophages over the 48-hour period. Also 
the effects of "immune" and "normal" sera on the cellular 
clearance of conidia were noted.
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RESULTS
All the test animals were skin test negative when checked prior to 
sensitization. All control sites (PBS and distilled water) were also 
nonreactive.
A rabbit sensitized with viable S_, schenckii 425 im reacted to 
intradermal injections of merthiolate-killed schenckii 425 conidia 
and hyphae, as well as to crude protoplasm (0.267 mg protein/0.1 ml). 
Arthus and delayed reactions were negative 2 days after sensitization, 
but both were positive at 5 days. In another rabbit similarly sensi­
tized, protoplasm (3.0 mg protein/0,1 ml) yielded a positive Arthus 
reaction, but only a borderline delayed reaction on the fifth day fol­
lowing injection.
Two and 5 days following initial injection, the rabbit which re­
ceived merthiolate-killed schenckii 425 iv was nonreactive to intra­
dermal injections of both killed cells and protoplasm (0.267 mg protein/ 
0.1 ml). However, positive Arthus and delayed reactions appeared 1 week 
post-injection. Also a similarly sensitized rabbit yielded a positive 
Arthus reaction, but a negative delayed reaction at the 1 week interval.
Two days following aerosol immunization, 4 rabbits were nonreactive 
to intradermal injections of killed cells and protoplasm (0.267 mg pro­
tein/0.1 ml). On the third day following initial exposure, the entire
20
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group of rabbits was Arthus positive, as well as being skin test (de­
layed reaction) positive to both antigens.
Two rabbits sensitized with viable schenckii 425 im showed the 
first qualitative agglutinin reaction at 1 week. These agglutination 
tests (figure 1) indicated the 2 rabbits had a maximum titer of 1:512 
and 1:1024 respectively.
A rabbit sensitized with repeated iv injections of merthiolate- 
killed 2° schenckii 425 did not show a positive agglutinin reaction 
until 2 weeks. The maximum agglutinin titer mounted by this rabbit 
was 1:512 at 158 days post-sensitization.
Two rabbits exposed to a single and double aerosol inoculation 
of viable schenckii 425 conidia (4 rabbits altogether) showed ini­
tial positive agglutinin reactions at 3 and 5 days respectively. Two 
rabbits similarly exposed to a single aerosol of viable conidia 
yielded a 1:64 agglutinin titer at 13 days following aerosolization. 
Two other rabbits, both of which were re-exposed to a second aerosol 
of viable conidia had a 1:64 titer at 16 and 19 days respectively 
post-aerosolization.
One of the 2 rabbits sensitized with viable schenckii 425 im 
first showed a positive precipitin reaction at approximately 3 weeks, 
whereas the other rabbit similarly sensitized did not show a positive 
reaction until 48 days. Precipitin testing (figure 3) showed these 
2 rabbits maximum titers of 1:4 at 85 and 176 days respectively.
The rabbit sensitized with repeated iv injections of merthiolate- 
killed schenckii 425 yielded the first observable precipitin titer 
171 days following initial inoculation. The first reaction (and maxi-
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mum titer) was 1:2.
Fungistatic activities of cell-free serum from all test animals 
and control animals are fully outlined in table 1,
Migration inhibition factor (MIF) assays are presented in table 
2, The data have been tabulated in terms of % migration (migration 
index) when compared to controls lacking antigen.
A large composite outline of fungicidal activity of rabbit al­
veolar macrophages in 10% "immune" serum or 10% "normal" serum is 
summarized in table 3, The tabulated values indicate the viable popu­
lation of conidia remaining at each time interval.
Phagocytic activities of macrophages from the lungs of both sen­
sitized and unsensitized rabbits are indicated in figures 4-8.
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Days following initial inoculation
Figure 1 Agglutination titers of sera collected from 2 rabbits sensitized with viable £. schenckii 425 
im (solid line and broken line) and 1 rabbit sensitized with merthiolate-killed S. schenckii 
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Days following initial exposure
Figure 2 Agglutination titers of sera collected from 2 rabbits which received 1 aerosol exposure (solid 
line and broken line) of viable S_. schenckii 425 conidia and 2 rabbits which received 2 aerosol 
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Days following initial inoculation
Figure 3 Precipitin titers of sera collected from 2 rabbits sensitized with viable £, schenckii 425 im 
(solid line and broken line) and 1 rabbit sensitized with merthiolate-killed £, schenckii 425 
iv (dotted line)
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Table 1 Fungistatic Activities of Cell-Free Serum From sensitized and Unsensitized Rabbits
Sensitized Rabbits (Test) Unsensitized Rabbits (Control)
Mode of Sensitization
Rabbit sensitized with 
viable S. schenckii 425 i.m.
Serum dilutions:
Difference in colony 
number between 0 hrs. 
and 12 hrs. Serum dilutions:
Difference in colony 
number between 0 hrs. 
and 12 hrs.
Difference in the changes 
between the test and 
control rabbits
1:10 —8 1 ID -35 + 27
1: 50 +10 1 50 + 20 -10
1: 100 -50 1 100 -31 -19
1:200 + 2 1 200 + 1 + 1
1:500 t6 1 500 + 30 -24
Rabbit sensitized with 
viable S. schenckii 425 i.m.
Difference in colony 
number between 0 hrs. 
Serum dilutions: and 12 hrs. Serum dilutions:
Difference in colony 
number between 0 hrs. 
and 12 hrs.
Difference in the changes 
between the test and 
control rabbits
1:10 + 2 1 10 -7 + 9
1:50 -54 1 50 +1 -55
1: 100 -20 1 100 +57 -77
1: 200 -27 1 200 +30 -57
1: 500 -3 1 500 + 37 -40




Difference in colony 
number between 0 hrs. 
and 12 hrs. Serum dilutions :
Difference in colony 
number between 0 hrs. 
and 12 hrs.
Difference in the changes 
between the test and 
control rabbits
1:20 -81 1 20 -145 +64
1: 100 -109 1 100 -8 -101
1:200 -109 1 200 +83 -192
1:400 -98 1 400 +89 -187
1:1000 -69 1 1000 + 24 -93
Rabbit which received one aerosolization 
with viable S. schenckii 425 conidia
Difference in colony 
number between 0 hrs. 
Serum dilutions: and 12 hrs. Serum dilutions:
Difference in colony 
nxamber between 0 hrs. 
and 12 hrs.
Difference in the changes 
between the test and 
control rabbits
1:10 -53 1 10 -27 -26
1:50 -29 1 50 -25 -4
1:100 -8 1 100 +21 -29
1:200 -13 1 200 +3 -16
1:500 0 1 500 + 13 -13
Rabbit which received one aerosolization 
with viable S. schenckii 425 conidia
Difference in colony 
number between 0 hrs. 
Serum dilutions: and 12 hrs. Serum dilutions:
Difference in colony 
number between 0 hrs. 
and 12 hrs.
Difference in the changes 
between the test and 
control rabbits
1:10 -34 1 10 -27 -7
1:50 -23 1 SO -25 -2
1:100 +8 1 100 + 21 -13
1:200 +9 1 200 +3 +6
1:500 -1 1 500 + 13 -14
Rabbit which received two aerosolizations 
with viable S. schenckii 425 conidia
Difference in colony 
number between 0 hrs. 
Serum dilutions: and 12 hrs. dilutions :
Difference in colony 
number between 0 hrs. 
and 12 hrs.
Difference in the changes 
between the test and 
control rabbits
I: 10 -31 1 10 -27 -4
1:50 -32 1 50 -25 -7
1:100 + 28 1 100 + 21 + 7
1:200 -17 1 200 + 3 -20
1:500 -26 1 SCO + 13 -39
Rabbit which received two aerosolizations 
With viable S. schenckii 425 conidia
Difference in colony 
number between 0 hrs. 
Serum dilutions: and 12 hrs. dilutions:
Difference in colony 
number between 0 hrs. 
and 12 hrs.
Difference in the changes 
between the test and 
control rabbits
1: 10 — 46 1 10 -27 -19
1:50 -48 1 50 -25 -23
1:100 + 23 1 100 + 21 + 2
1:200 + 20 1 200 + 3 + 17
1:500 0 1 500 + 13 + 13




























S. schenckii 425 Protoplasm 
(0.27 mg protein/0.1 ml) 
Incorporated
Merthiolate-killed 







94.3% ***{94.6%, 94.0%) 
93.6% ***(92.7%, 94.5%)
96.2% ***(95.2%, 97.2%) 
97.8% ***(97.0%, 98,6%)
Rabbits Sensitized to Merthio­






68,2% ***{65.1%, 71.3%) 
74.1% ***(73.7%, 74.5%)
66.7% ***(62.8%, 70.6%) 
65.5% ***(63.8%, 67.2%)
Rabbits Sensitized to Viable 










Rabbits Sensitized to 1 






77.0% ***(75.4%, 78.6%) 
77.9% ***(80,3%, 75,5%)
67.6% ***(67.2%, 67.9%) 
72.3% ***(73,2%, 74.1%)
Rabbits Sensitized to 2 









81.6% ***(76.4%, 86.7%) 
82.7% ***(81.0%, 84,3%)
system contained 10% "immune" 
system contained 10% "normal" 
)= results from 2 separate
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Time (hours following initiation of culture of conidia and macrophages)
Figure 4 Phagocytic activity of alveolar macrophages from an unsensitized rabbit 
solid lines= culture contains 10% "immune" serum 
broken lines= culture contains 10% "normal" serum
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Figure 5 Phagocytic activity of alveolar macrophages from a rabbit sensitized with merthiolate-killed 
2» schenckii 425 iv
solid lines= culture contains 10% "immune" serum 
broken lines= culture contains 10% "normal" serum
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Figure 6 Phagocytic activity of alveolar macrophages from a rabbit sensitized with viable S. schenckii 
425 iv
solid lines® culture contains 10% "immune" serum 
broken lines® culture contains 10% "normal" serum
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Figure 7 Phagocytic activity of alveolar macrophages from 2 rabbits which received 1 aerosol exposure to 
Ê.' schenckii 425 conidia
solid lines= culture contains 10% "immune" serum 
broken lines= culture contains 10% "normal" serum
values above plots= maximum number of conidia within a single macrophage 
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Figure 8 Phagocytic activity of alveolar macrophages from 2 rabbits which received 2 aerosol exposures to 
schenckii 425 conidia
solid lines= culture contains 10% "immune” serum 
broken lines= culture contains 10% "normal" serum
values above plots= maximum number of conidia within a single macrophage 




Mechanisms of resistance to sporotrichosis are still obscure. 
Various reports (8, 26, 44) indicate that standard serological pro­
cedures are of some diagnostic value in extrapulmonary and chronic 
lymphocutaneous cases, but the actual role of the humoral response 
in the recovery from or protection against the disease is equivocal. 
Kite (29) stated that passive transfer of immune sera from infected 
animals failed to protect recipients against subsequent homologous 
challenge to Coccidioides immitis. Cryptococcus neoformans, 
Histoplasma capsulatum, and Candida albicans. However, antibody 
titers sufficiently high to be protective may not have been present. 
If one assumes that sufficient specifically immune globulins were 
being transferred, then one may postulate that antibodies, by them­
selves, are not protective against these diseases. A recent conver­
sation with Leo Kaufman (27) at the Center for Disease Control 
prompted him to say that to his knowledge, he was unaware of any type 
of antibody response that appeared to be protective against sporo­
trichosis.
Working with Ĉ . neoformans. Diamond (13) found evidence for an 
antibody-dependent cell-mediated cytotoxicity. Hyperimmune human
3+
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serum, specific against Ĉ . neoformans, cultured with human blood 
mononuclear cells significantly reduced the original population of 
C. neoformans.
Delayed hypersensitivity as determined by skin reactivity to 
sporotrichin or some other suitable antigen, has proved valuable in 
the detection of sporotrichosis (past and present infection). Ex­
perimental human infection with schenckii results in positive 
skin tests as early as the fifth day after lesions appear (29). Skin 
tests are of particular value since these cellular reactions are fre­
quently detectable before the humoral response (29, 52). Specificity 
of the skin test varies accordingly to the test antigen, dilution, and 
techniques employed, but the yeast-phase antigens of S_, schenckii 
appear to be highly specific.
Skin Testing
In the present study, a rabbit injected intramuscularly with via­
ble schenckii 425 reacted to both merthiolate-killed and protoplas­
mic skin test antigens 5 days following initial inoculation. Agglu­
tinins first appeared at about the scime time (1 week post-inoculation) , 
but precipitins did not appear until 28 days following inoculation (see 
sections later in discussion). These results are consistent with other 
observations that cell-mediated responses frequently appear before hu­
moral responses. The concentration of protoplasmic test antigen was 
crucial: 0.27 mg protein/injection was insufficient to elicit a de­
layed reaction, while 3.0 mg protein/injection did so. A minimum ef­
fective dosage of protein was not performed.
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A rabbit sensitized with repeated iv injections of merthiolate- 
killed schenckii showed delayed dermal sensitivity to both skin 
test antigens at 1 week post-inoculation, but not at 5 days. In this 
case, animals sensitized with non-viable inoculum took a longer period 
of time to mount a response than did animals sensitized intramuscularly 
with viable inoculum.
All 4 rabbits receiving aerosolized conidia developed delayed 
skin reactivity in 3 days. Sensitization by inhalation evidently must 
evoke a delayed immune response with an equal or greater efficiency than 
parenterally administered viable or non-viable conidia.
Sethi (49) demonstrated that the majority of mice receiving aero­
solized conidia had positive lung cultures for schenckii. The same 
was shown to occur in rabbits in this study. Perhaps the antigen in the 
alveoli of the rabbit remained in contact with the tissues for a rela­
tively longer period of time (compared to the antigen administered paren­
terally) and was cleared less rapidly, thereby serving as a more persis­
tent source of sensitization. Inoculum sizes and the time required for 
contact of conidia with the immune system are 2 other variables which 
must also be considered. Although the parenterally (im and iv) sen­
sitized rabbits received repeated inoculation, the inoculum involving 
the aerosolization study was 6 times as great (6,0 ml of 5.5 X 10^ 
conidia/ml). It also seemed logical that conidia entrapped within al­
veoli of lung tissue would be less susceptible to non-specific clearance 
by PMNs than would be conidia in the circulation or muscle tissue. If 
this is true, then perhaps the time required for the conidia to sensi­
tize the T-lymphocytes, and in turn activate monocytes and macrophages
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may be lessened compared to the time necessary to activate mononu­
clear cellular constituents by parenterally administered antigen.
Two major conclusions can be deduced from the skin testing pro­
cedures conducted on these groups of rabbits. First, viable immuno­
gens appear to confer a more rapid development of skin hypersensi­
tivity to test antigens. This is in agreement with the literature 
(15). Secondly, pulmonary exposure to aerosolized conidia represents 
a very effective and efficient method of reducing the time required for 
mounting delayed skin hypersensitivity.
Wilson (60) reported that an experimentally infected (with 
schenckii) human reacted to an intradermal skin test antigen as early 
as the fifth day. This is consistent with the skin responses of the 
test rabbits which received aerosolized conidia in this study.
Despite small variations in time of onset of skin sensitivity, all 
rabbits did develop delayed hypersensitivity. It is interesting to 
note all 3 groups of rabbits sensitized by different routes presented 
no overt evidence of clinical sporotrichosis. No nodular lesions were 
noted on the limbs of the rabbits which received im injections of via­
ble schenckii. Their immune status, demonstrated by in vivo and in 
vitro reactions, may therefore have aborted overt infection.
Agglutination Testing 
Agglutination testing is a commonly used serological procedure for 
the rapid diagnosis of sporotrichosis. More than 2 decades ago, Norden 
(44) noted agglutinins appeared in rabbits approximately 2 weeks fol­
lowing a single iv injection of viable mycelial-phase Ŝ . schenckii. 
Following a single im injection of the same inoculum, he was unable to
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detect a response. Bluraer (8) related that the tube agglutination 
test was both very specific and sensitive in a comparative study she 
made of various serological techniques using human sera (from cul­
turally proven cases of cutaneous, subcutaneous, and extracutaneous 
forms of sporotrichosis) and merthiolate-killed schenckii antigen.
In this study, 2 rabbits injected with viable schenckii im 
yielded agglutinin titers which first appeared 1 week following 
initial injection. Maximum titers (1;512-1i1024) appeared approxi­
mately 6h months post-injection, and remained elevated for at least 
1 year.
A rabbit which received repeated iv injections of merthiolate- 
killed schenckii mounted a peak agglutinin titer (1:512) which 
approximated the titers mounted by the 2 rabbits injected with viable 
S_, schenckii im. However, these 2 im Inoculated first mounted demon­
strable agglutinins 1 week sooner than the rabbit sensitized with mer­
thiolate-killed schenckii 425 iv.
Two rabbits which were exposed once to aerosolized conidia first 
exhibited agglutinin titers at 3 and 5 days respectively. Maximum 
levels of 1:64 were attained at the 13th day following aerosolization, 
and appeared even before a titer was demonstrable in the rabbit sensi 
tized with iv injections of killed schenckii. By the 13th day fol­
lowing inoculation, the parenterally (im and iv) sensitized rabbits 
mounted an agglutinin titer of 1:2, significantly lower than the 1:64 
titer mounted by the rabbits which received aerosolized conidia. Al­
though antibody formation is most frequently obtained (clinically as well 
as experimentally) by parenteral administration of immunogen, aerosoli-
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zation appeared to be a more efficient method of eliciting a humoral 
response. Serological studies of those rabbits receiving aerosolized 
conidia were abbreviated because they had to be sacrificed for cellular 
studies. However, I would expect the agglutinin levels of these rabbits 
to equal, or even surpass the levels attained by the rabbits sensitized 
by ira or iv injection. This seems plausible since 1:64 agglutinin ac­
tivity in the im and iv sensitized rabbits took 18 days and more than 3 
months longer respectively to occur than in the rabbits which received a 
single aerosol.
Two rabbits which were exposed twice to aerosolized conidia mounted 
an agglutinin titer (following the second exposure) identical to the 
titer mounted by the 2 rabbits which received only a single exposure. 
Agglutinins appeared in the doubly exposed rabbits at approximately the 
same time as did the agglutinins in the singly exposed rabbits. I am 
not convinced that the enhanced response was significant. However, since 
only 5 days elapsed between the second exposure and animal sacrifice, 
perhaps the time interval was too short to note significant amplification 
of the response.
With reference to all the test animals used in the agglutination 
studies, those rabbits which received viable immunogen responded sooner 
than the rabbit which received killed inoculum.
The 8 uninoculated rabbits tested for agglutinins either exhibited 
a maximum titer of 1:2 or no titer at all. This marginal reactivity 
could be attributed to either subclinical infection, cross reaction, or 
the value could be discounted as insignificant. Since microscopic analy­
sis was necessary to determine the endpoints, a 1-tube variation in 
either direction could be considered experimental error.
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Karlin and Nielsen (26) recognized some minor cross reactivity of 
hyperimmune antiserum against schenckii with antigens of other fungi* 
However, when compared to other standard serological procedures, the 
tube agglutination was quite specific and sensitive.
Precipitation Testing 
Precipitin reactions are not as sensitive as agglutination reac­
tions. Only 20 pg of antibody can be detected in the former (15). 
Probably for this reason, low precipitin titers are of more signifi­
cance than corresponding agglutinin titers. The rate of precipitin 
appearance is also considerably slower than that of agglutinin reac­
tions, making the former less desirable as a routine diagnostic pro­
cedure.
In this study, 2 rabbits injected with viable schenckii im 
produced only slightly elevated precipitin titers. It took I of these 
animals 3 weeks to mount a 1:2 precipitin titer, and another 9 weeks 
for the titer to reach its maximum at 1:4, The other rabbit similarly 
inoculated took 7 weeks for an initial precipitin titer of 1:2 to ap­
pear, and 18 weeks later, the maximum titer of 1:4 was reached,
A rabbit sensitized with repeated iv injections of merthiolate- 
killed S. schenckii took 24 weeks to mount an initial (and maximum) 
precipitin titer of 1:2,
It is noteworthy that the 2 rabbits which received viable 
schenckii im mounted demonstrable precipitin titers within 28 days of 
each other. The rabbit sensitized with iv injections of killed inocu­
lum took an additional 4% months to mount a demonstrable titer, I 
attribute little significance to the quantitative differences in the
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precipitin titers between these 2 groups of rabbits; however, the fact 
that any titer was achieved at all is important. I also contend that 
the substantial time lag apparently necessary for the iv sensitized ani­
mal to react to non-viable immunogen is significant.
Eisen (15) and Mackaness and Blanden (35) stated that living cells 
are required to stimulate the maximum delayed-type immune response. It 
certainly appears that viable cells may also function better than killed 
cells to stimulate precipitin reactions. The difference in time re­
quired for initial demonstration of antibody is not as obvious in the 
agglutination reactions, although the same trend exists. This obser­
vation may be real or may be attributed to increased agglutination 
testing (compared to precipitin testing) in the initial stages of sen­
sitization, If the former is true, the greater sensitivity inherent 
in agglutination testing (compared to precipitin testing) could account 
for this phenomenon.
Cell-free Serum Studies
Cell-free serum fungistasis has been documented by a number of re­
searchers (4, 7, 32, 47). Baum and Artis (4) indicated that although 
human serum inhibited the growth of schenckii, the effect was not so 
pronounced as noted for other fungi tested.
As evidenced by my work, in most instances cell-free serum from all 
sensitized rabbits was fungicidal at the lower dilutions. Sera col­
lected from unsensitized rabbits were similarly fungicidal, but the 
fungicidal activity of these sera appeared to be even more restricted 
to the lower dilutions (compared to the sera of the sensitized rabbits).
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Unequivocal comparison of the fungicidal activity of sera procured from 
the 3 different groups of rabbits is not possible. However, when com­
pared to the control sera, fungicidal activity was present in the ma­
jority of serum dilutions. From these tests alone, participation of 
antibodies in cell-free fungistasis seems plausible. The increased 
fungicidal activity of serum from test animals (when compared to respec­
tive controls) yields support to immune globulins being the active frac­
tion involved in fungistasis. Since lability studies were not conducted 
in this research, participation of complement cannot be ruled out as a 
possible mechanism.
Migration Inhibition Factor (MIF)
The in vitro macrophage migration inhibition factor test is common­
ly correlated with delayed type hypersensitivity to various microorgan­
isms. Neta and Salvin (42) noted reduced migration patterns of guinea 
pig peritoneal macrophages when incubated with the same antigen to which 
they were originally sensitized (Ĉ , albicans). It was also noted that 
these same guinea pigs were resistant to experimental candidiasis.
The presence of a population of sensitized lymphovytes is neces­
sary for migration inhibition. It is these cells that become sensitized 
and produce the soluble mediators, or lymphokines (of which MIF is one) 
which inhibit the migration of macrophages (29), The inhibition of 
macrophage migration is possible upon the addition of specific antigen, 
even when as little as 1% of the cell suspension consists of sensitized 
lymphocytes (15),
As expected, the migration of alveolar macrophages from unsensitized
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rabbits was not inhibited appreciably with the addition of soluble and 
cellular antigens of schenckii. In contrast, migration patterns of 
alveolar macrophages from rabbits sensitized to schenckii parenteral- 
ly (im and iv) and by inhaled conidia were substantially reduced. 
Kirkpatrick (28) stated that a 20% reduction of migration, when com­
pared to the controls without antigen, constituted a positive MIF test. 
According to this criteria, macrophages taken from the rabbits sensi­
tized with duplicate aerosolization, yielded borderline MIFs when incu­
bated with protoplasm of schenckii. When incubated with merthiolate- 
killed cells, the macrophages from these animals in this study yielded 
unquestionably positive MIF patterns.
It is interesting to note in all but 1 of the systems involving sen­
sitized alveolar macrophages, serum from sensitized rabbit enhanced mi­
gration inhibition over that seen with non-immune serum. The difference 
in the MIF patterns was only 1.2% in the exceptional situation. This ob­
servation is difficult to explain since MIF is mediated through sensi­
tized T-lymphocytes and not cell-free serum. Although greater MIF ac­
tivity was noted in the systems which incorporated serum from sensitized 
rabbit, the systems which utilized serum from nonsensitized rabbit also 
yielded positive MIF tests. This is to be expected since the macro­
phages were also sensitized, however this observation would substantiate 
claims that MIF is qualitatively dependent upon sensitized cells as 
opposed to immune serum. Quantitatively, immune serum may very well 
enhance the degree of migration inhibition already expressed by sensi­
tized alveolar macrophages as observed in this study.
Another generality that seems evident is that the killed cellular
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antigen (protein content not determined) prompted a better MIF re­
sponse than to the protoplasmic antigen (0.27 mg protein/0.1 ml). The 
most obvious explanation for this is that the cells probably presented 
a greater concentration of antigen than the protoplasm. Since the 
cellular antigen was washed prior to use in the MIF tests, it is doubt­
ful that residual merthiolate toxicity would be present to inhibit mi­
gration inhibition. Perhaps the macrophages and lymphocytes elaborated 
proteinases which degraded reactive protein. The chitin content in the 
filamentous-phase of schenckii is quite high (11), and although 
rabbit alveolar macrophages are richly endowed with hydrolytic enzymes 
(10), chitinase activity in mammalian cells is marginal (19). If 
chitin in the cell walls of S_. schenckii in any way protects cell wall 
peptides from structural degradation by the action of macrophage pepti­
dases, then these peptides would retain their immunogenicity. Immuno­
chemical studies performed by Shimonaka (51) indicated that peptides are 
generally responsible for stimulation of delayed-type hypersensitivity 
reactions. In the present study, the observation that cellular antigen 
provided greater stimulation in the MIF tests than protoplasmic antigen 
could be because of greater exposure to wall antigen than to protoplas­
mic antigen during sensitization.
On the basis of the MIF test alone, it is difficult to substantiate 
claims that living cells are the most effective immunogens in the sensi­
tization of delayed hypersensitivity. In fact, the MIF patterns of macro­
phages taken from a rabbit sensitized with killed schenckii showed 
greater inhibition, in certain instances, than the patterns involving 
macrophages from animals sensitized with viable cells of the fungus.
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Quantitatively, however, the difference in migration patterns is one of 
questionable significance.
Cellular Fungicidal Activity and Phagocytosis 
The rabbit alveolar macrophage has the capacity to reduce the via­
bility of schenckii conidia vitro, as evidenced by the cellular 
fungicidal assays conducted in this study. This activity was observed 
with alveolar macrophages taken from both sensitized and nonsensitized 
rabbits. The macrophages taken from rabbits sensitized by parenteral 
(im and iv) injection and by aerosolization showed significantly eleva­
ted fungicidal activity compared to the macrophages taken from non­
sensitized animals. The difference in fungicidal activity between 
macrophages taken from animals inoculated with killed schenckii iv 
and those-sensitized with viable inoculum im is probably insignificant. 
However, rabbits sensitized with aerosolized conidia yielded macrophages 
that demonstrated much greater fungicidal activity than macrophages taken 
from any of the other animals.
An obvious and somewhat expected trend that must be mentioned is that 
in all vitro tests for cellular fungicidal activity, the macrophages 
showed greater activity when serum from sensitized rabbit was incorpora­
ted. This generality suggests the presence of an active humoral substance, 
perhaps an opsonin, that aids the macrophage in phagocytosis
Diamond (13) recently observed an antibody-dependent cell-mediated 
cytotoxicity with neoformans. Prevention of phagocytosis by mono­
nuclear cells was drug induced. However, a much greater proportion of 
original C_, neoformans inoculum was eliminated when both leukocytes and 
antibody were present, than when either or both of these components were
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absent. Although not tested in this study, cytotoxic humoral factors 
may have also been present and contributed to fungal death.
Rabbits sensitized with viable cells yielded macrophages with 
greater phagocytic activity (i.e. conidia/macrophage) than found in 
macrophages from animals sensitized with killed cells. This difference 
was especially obvious with animals exposed to aerosolized inoculum.
If the latter observation is reproducible, then the alveolar macrophages 
possibly provide significant protection againat inhaled conidia.
Publications dealing with cell-mediated immunity and delayed hyper­
sensitivity in pulmonary sporotrichosis are not abundant. H. capsulatum 
probably represents the most discussed and studied model of a pulmonary 
mycosis. Conclusions and hypotheses may be applicable to pulmonary 
sporotrichosis. Wilson (60) philosophized by saying, "As Nature does 
not bother to invent numerous basic processes where one will serve ade­
quately, it is extremely unlikely that she has furnished the human body 
with a different mechanism for resisting each infectious disease. In­
stead of emphasizing the differences in immunologic response, we should 
seek diligently for similarities..."
For some time H. capsulatum has been thought to be an intracellular 
parasite, able to reside and multiply within reticuloendothelial cells. 
Howard’s (22) work confirmed this after a 24-hour residence within sensi­
tized macrophages. In the present study, following a 24-hour residence 
within sensitized rabbit alveolar macrophages, schenckii was still 
found to retain viability, although the original inoculum had been re­
duced drastically.
In another study conducted by Howard (21), the intracellular sur-
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vival of _H, capsulatum in sensitized mouse peritoneal macrophages was 
less than within unsensitized macrophages. He also attached much sig­
nificance to lymphocytes as mediators to this enhanced fungicidal ac­
tivity. Despite the fact Howard's work dealt with a different organism, 
a different host, and a different source of macrophages (peritoneal 
versus alveolar), I was also able to show evidence of loss of viability 
of conidia in macrophages.
The viability of schenckii declined decisively during the first 
24 hours when cultured vitro with alveolar macrophages. A longer in­
cubation would be required (in excess of 48 hours) to determine the 
eventual plight of the schenckii inoculum, but based over 24 hours,
it is obvious that the action of the macrophages on the conidia is 
fungicidal. Perhaps in the in vivo situation, viable organisms may be 
inactivated by nonspecific factors that are not inherent in the in 
vitro macrophage assays; nonspecific killing by fungicidal globulins, 
PMNs, or macrophages which retain their fungicidal activity over a 
longer period of time. Rabbit alveolar macrophages, in addition to 
being antifungal, are also able to phagocytize the conidia efficiently. 
This was obvious with macrophages taken from both sensitized and un­
sensitized rabbits.
It is my contention that the parallel between phagocytosis and 
fungicidal activity is not coincidental. The overall reduction of 
schenckii conidia viability, when incubated with alveolar macro­
phages, generally corresponds to increased phagocytosis. Immune sera 
in each of these models in table 3 affords a greater overall fungi­
cidal activity compared to the systems incorporating normal sera. This
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trend is also evident in the phagocytosis experiments.
Cellular studies in the present research show that the route of an­
tigen administration is important in determining the fungicidal and pos­
sibly phagocytic responses of rabbit alveolar macrophages. Rabbits sen­
sitized by aerosolization yielded cells which were significantly more 
fungicidal and perhaps more phagocytic than cells from the rabbits sen­
sitized parenterally. The difference between fungicidal activity and 
phagocytic activity among the im and iv sensitized rabbits should be 
discounted as insignificant.
Rabbits have the advantage over mice and other small animals, in 
that greater yields of alveolar macrophages are possible, therefore 
eliminating any need to pool cell populations. In order to better eval­
uate the cellular response to pulmonary sporotrichosis, alveolar macro­
phages were used in preference to peritoneal macrophages. In addition 
to alveolar macrophage suspensions being quite pure (generally less than 
1% PliN contamination), these cells permit a more direct interpretation 
of data obtained from studies of respiratory diseases and eliminate the 
extrapolation that would be necessary if peritoneal macrophages were 
used (39).
I was hesitant to attempt to increase the yield of alveolar macro­
phages through the use of BCG as described by Myrvik (40). Although a 
larger cell yield would have been mechanically helpful, working with 
tuberculin sensitive rabbits would have introduced another variable, 
making interpreatation more difficult.
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General Comments
Since only 2-3 weeks elapsed from the time of initial aerosol ex­
posure to the time of sacrifice, the rabbits most closely represented 
examples of acute sporotrichosis. Although stained smears of alveolar 
macrophage preparations in culture with conidia of schenckii re­
vealed mononuclear cells, PMNs may have been the primary cell re­
sponding to earlier inflammation im vivo.
A much longer time period elapsed between initial exposure of an­
tigen and sacrifice of the im sensitized rabbits. Therefore, based 
solely on this protracted time period, these rabbits more nearly simu­
lated chronic lymphocutaneous sporotrichosis (although actual infec­
tion was not confirmed in these animals). Compared to the aerosol ex­
posed animals, longer periods of time were required for agglutinins to 
appear. Although unequivocal comparisons regarding cell-free serum 
fungistasis are not possible, cellular fungicidal activity of the pa­
renterally sensitized rabbits did not attain the magnitude of that 
achieved by cellular preparations from rabbits sensitized by aerosol.
Pulmonary sporotrichosis is a very real, and perhaps underesti­
mated problem in urban hospitals (46), Just how the human alveolar 
macrophage and humoral substances act against the fungus in vivo re­
mains to be seen. From the data presented, it is obvious that when 
compared with the unsensitized rabbit, the sensitized rabbit has alveo­
lar macrophages with an increased capacity to respond to schenckii 
in vitro. Isolated tests indicate that the cells are highly phago­
cytic and fungicidal toward schenckii conidia in tissue culture.
The question that must be answered is: Is this what really happens in
the infected animal? Do these alveolar macrophages act as killer cells.
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or is it a situation of antibody-dependent cell-mediated cytotoxicity 
as Diamond (13) suggested in cryptococcosis? It could be both these 
activities working in conjunction with one another. Obviously experi­
ments precluding phagocytosis are in order to determine whether a cell- 
mediated (non-phagocytic) antibody-mediated cytotoxicity is active in 
sporotrichosis. Finally, as a follow-up to the cell-free serum studies 
performed, additional work should be conducted involving heat-inacti­
vated serum to determine whether complement and other heat-labile serum 
factors are anti-fungal. Examination of serum proteins by separation 
may isolate specific anti-fungal fractions.
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SUMMARY AND IMPLICATIONS
Obviously, both humoral and cellular constituents (alveolar macro­
phages) participate in anti-Sporothrix activity in rabbits, thereby con­
tributing to host resistance. Although cell-free serum was fungicidal 
at the majority of the dilutions tested, a well defined trend was not 
evident. However, immune serum did significantly enhance the phagocytic 
and fungicidal activity of alveolar macrophages compared to the systems 
incorporating normal serum. This observation, I believe, is attributable 
to the presence of specific opsonins in the immune serum. The concom- 
mitant reduction of schenckii in culture with alveolar macrophages 
coupled with increased phagocytic activity provides evidence for a 
phagocytic mechanism in host resistance to sporotrichosis.
Rabbits sensitized with viable schenckii, especially by the aero­
sol route, appeared to demonstrate greater phagocytic and fungicidal ac­
tivity compared to rabbits which received killed inoculum. This would 
imply that immunization with viable schenckii confers a more ef­
ficient host resistance of rabbits against Sporothrix than killed cells.
51
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